0001367644-24-000008.txt : 20240227
0001367644-24-000008.hdr.sgml : 20240227
20240227202640
ACCESSION NUMBER: 0001367644-24-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LINDAHL RICHARD S
CENTRAL INDEX KEY: 0001196632
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 24689667
MAIL ADDRESS:
STREET 1: NEXTEL
STREET 2: 2001 EDMUND HALLEY DR
CITY: RESTON
STATE: VA
ZIP: 20191
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wk-form4_1709083590.xml
FORM 4
X0508
4
2024-02-21
0
0001367644
Emergent BioSolutions Inc.
EBS
0001196632
LINDAHL RICHARD S
400 PROFESSIONAL DRIVE, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Chief Financial Officer
0
Common Stock
2024-02-21
4
D
0
4012
2.71
D
168980
D
Common Stock
2024-02-23
4
F
0
517
2.74
D
168463
D
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. On February 21, 2024, the final certification date, the Compensation Committee certified the achievement of the 2021-2023 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 4,012 shares previously reported on February 24, 2021.
Represents shares of common stock withheld to pay taxes.
This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in its next proxy statement
/s/ Jennifer Lynne Fox, Attorney-in-fact
2024-02-27